Cincinnati, OH – September 14, 2020:  Cordata Healthcare Innovations is pleased to announce its collaboration with the Cleveland, OH-based Family Care Path, Inc.  This partnership will allow Cordata to extend its platform’s features to include rich genetic and genomic risk stratification, helping to grow our client disease programs through familial risk identification.  It also allows for whole-person risk profiling that considers future health risk outside of current in-process disease care by integrating Family Care Path’s MyLegacy Software tool.

Complex and chronic diseases, like those managed on the Cordata platform, tend to run in families.  The typical disease care coordinator commonly does not have access to a patient’s family history, important genetic risk factors, or genetic testing results.  Unlike single-gene disorders, complex disorders may not have clear-cut patterns of inheritance, yet knowledge of mutations or family history can be a powerful tool in planning care and driving precision medicine. Studies have long established that genes are contributors to chronic conditions such as cardiovascular disease, cancer, diabetes, obesity, rheumatoid arthritis (RA), Alzheimer’s disease (AD), and depression. Only recently, however, has it become possible to measure individual-level risks for these chronic diseases.  Considering the fact that a majority of older adults (>60%) live with two or more chronic conditions, bringing this information to bear in a care coordination setting can be revolutionary.

Gathering comprehensive genetic and familial profiles on patients is typically a very manual process.  Normally, genetic assessment and testing are laser-focused on a single disease area, like cancer or in the new area of cardiogenomics, and critical information is commonly missing across the patient’s co-morbid conditions.  With the Cordata+Family Care Path solution, the impact on patient care coordination will be felt immediately with access to more genetic data enabling precise care planning, while the Cordata platform increases pathway adherence, patient engagement and satisfaction.  Adding the Family Care Path toolset to Cordata amps up the disease profile from standard histology, stage, acuity, risk and even social determinants – to considerations of the critical genetics driving disease occurrence and recurrence. Together these solutions will reduce costs and offer a more holistic management of patients along their care continuum.

”At Cordata we are striving to provide a more complete picture of each complex and chronic diseased patient.  This includes clinical, social, emotional – and now genetic.  The more patient profile information our client disease programs and their care teams have – the more precise their interventions can be.  Cordata’s mission is about moving the needle for the people affected by costly and life-altering diseases.  It takes a village to do this special kind of technology work and the team at Family Care Path shares our values.  We are excited to see this work unfold.” says Gary Winzenread, Cordata’s President and CEO.

“We founded the company to introduce the web-based clinical decision support application MyLegacy, which uses proprietary algorithms based on practice guidelines developed by the Cleveland Clinic Genomic Medicine Institute.  Finding a partner like Cordata, allows us to bring this product to on-the-ground care teams and their patients – at lightning speed. Together, we are going to change what disease and person-centric care coordination looks like.” says Dave McKee, Family Care Path CEO

About Cordata Healthcare Innovations, LLC

Cordata’s specialty care coordination platform helps healthcare organizations more effectively treat people with chronic complex diseases and generate better clinical and business outcomes through effective patient management and retention along complex care paths. Physicians, nurse navigators, care coordinators, service-line directors and business executives at 100+ hospitals and health systems rely on Cordata for timely and actionable insights. Learn more at

About Family Care Path

Family Care Path was formed in 2016 as a spin-off company from Cleveland Clinic Innovations with a mission to bring patient-benefiting products from the academic institute to market. The company introduced the web-based clinical decision support application MyLegacy, which uses proprietary algorithms based on practice guidelines developed by the Cleveland Clinic Genomic Medicine Institute.  The other products in their portfolio are CarePathConnect and CancerNav.  Find them here: